Patent Assignment
Reel/Frame 054005/0623
Change of Name
Recorded: 2020-10-07
Pages: 4
Assignor
REVITALID, INC.
Executed: 2020-04-06
Assignee
RVL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD, BRIDGEWATER, NEW JERSEY, 08807
Covered Property
(1)
Oxymetazoline Compositions
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 7, 2020
From: DEVRIES, TINA; JACOBS, DAVID
To: REVITALID, INC.
Reel/Frame 054000/0603 →
Security Interest
Jan 25, 2021
From: RVL PHARMACEUTICALS, INC.
To: CIT BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 055015/0762 →
Notice of Grant of Security Interest in Patents
Oct 12, 2021
From: RVL PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 057787/0507 →
Release of Security Interest
Oct 15, 2021
From: CIT BANK, N.A.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 057801/0484 →
Release of Patent Security Agreements
Oct 15, 2021
From: CIT BANK, N.A., AS COLLATERAL AGENT
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 057819/0436 →
Termination and Release of Security Interest in Patents Recorded at Reel 057787, Frame 0507
Nov 27, 2023
From: ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, AS ADMINISTRATIVE AGENT
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 065676/0610 →
Notice of Grant of Security Interest in Patents
Nov 27, 2023
From: RVL PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 065676/0617 →